BioAmp
BioAmp is developing point-of-care diagnostic tests that provide medical personnel with actionable results to direct the appropriate use of antibiotics. BioAmp utilizes a patented amplification technology to enable detection of low-abundance resistance biomarkers directly in patient samples.
Last updated on
About BioAmp
Founded
2017Estimated Revenue
$1M-$10MEmployees
1-10Funding / Mkt. Cap
$225KCategory
Industry
BiotechnologyLocation
City
San CarlosState
CaliforniaCountry
United StatesBioAmp
Find your buyer within BioAmp